MedTrace Logo

Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users

NCT04881942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-07-30

Study results available
· View outcomes & findings →

Summary

This is an open-label, 4-way crossover study designed to estimate the nicotine, glycerin, propylene glycol, menthol, formaldehyde, acetaldehyde, and acrolein levels in exhaled breath samples during use of four MarkTen® XL e-vapor products. The study will enroll approximately 32 adult e-vapor-using subjects at one site in the United States in High Point, NC.

Conditions

  • Tobacco Use

Interventions

OTHER

e-Vapor Product A

e-Vapor product XL25F

OTHER

e-Vapor Product B

e-Vapor product XL40CB

OTHER

e-Vapor Product C

e-Vapor product XL35WM

OTHER

e-Vapor Product D

e-Vapor product XL40MB

Sponsors & Collaborators

  • Cato Research

    collaborator INDUSTRY

  • Altria Client Services LLC

    lead INDUSTRY

Principal Investigators

  • Jeffery S Edmiston, PhD · Altria Client Services

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-27
Primary Completion
2017-04-21
Completion
2018-01-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04881942 on ClinicalTrials.gov